Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. (ParvOryx01)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Oryx GmbH & Co. KG
Sponsor:
Information provided by (Responsible Party):
Oryx GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01301430
First received: February 21, 2011
Last updated: November 19, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)
No publications provided by Oryx GmbH & Co. KG

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):